The treatment of peritoneal carcinomatosis in advanced gastric cancer: State of the art

International Journal of Surgical Oncology

Volumn 2014, Issue , 2014, Pages

  Montori, Giulia ^a   Coccolini, Federico ^b   Ceresoli, Marco ^b   Catena, Fausto ^c   Colaianni, Nicola ^b   Poletti, Eugenio ^b   Ansaloni, Luca ^b  

^a SPEDALI CIVILI   (Italy)

^b PAPA GIOVANNI XXIII HOSPITAL   (Italy)

^c MAGGIORE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT CHEMOTHERAPY; CARCINOMA; DIAGNOSTIC IMAGING; EARLY DIAGNOSIS; HUMAN; HYPERTHERMIC THERAPY; META ANALYSIS; METASTASIS; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PERITONEUM TUMOR; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGIONAL PERFUSION; REVIEW; STOMACH TUMOR; SURVIVAL; TREATMENT OUTCOME;

CARCINOMA; CHEMOTHERAPY, ADJUVANT; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COMBINED MODALITY THERAPY; DIAGNOSTIC IMAGING; EARLY DETECTION OF CANCER; HUMANS; HYPERTHERMIA, INDUCED; PERITONEAL NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84897811117     PISSN: 20901402     EISSN: 20901410     Source Type: Journal    
DOI: 10.1155/2014/912418     Document Type: Review

References (38)

1. Bertuccio P., Chatenoud L., Levi F., Praud D., Ferlay J., Negri E., Malvezzi M., la Vecchia C., Recent patterns in gastric cancer: a global overview. International Journal of Cancer 2009 125 3 666 673 2-s2.0-67650073366 10.1002/ijc.24290
2. Parkin D. M., Bray F., Ferlay J., Pisani P., Global cancer statistics, 2002. CA Cancer Journal for Clinicians 2005 55 2 74 108 2-s2.0-14944385553 10.3322/canjclin.55.2.74 (Pubitemid 40372904)
3. Okines A., Verheij M., Allum W., Cunningham D., Cervantes A., Gastric cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Annals of Oncology 2010 21 5 v50 v54 2-s2.0-77954322183 10.1093/annonc/mdq164
4. Nissan A., Garofalo A., Esquivel J., Cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy (HIPEC) for gastric adenocarcinoma: why haven't we reached the promised land? Journal of Surgical Oncology 2010 102 5 359 360 2-s2.0-77957326868 10.1002/jso.21619
5. Glehen O., Mohamed F., Gilly F. N., Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia. The Lancet Oncology 2004 5 4 219 228 2-s2.0-1642338676 10.1016/S1470-2045(04)01425-1 (Pubitemid 38391217)
6. Gill R. S., Al-Adra D. P., Nagendran J., Campbell S., Shi X., Haase E., Schiller D., Treatment of gastric cancer with peritoneal carcinomatosis by cytoreductive surgery and HIPEC: a systematic review of survival, mortality, and morbidity. Journal of Surgical Oncology 2011 104 6 692 698 2-s2.0-80053606329 10.1002/jso.22017
7. Kim J.-Y., Bae H.-S., A controlled clinical study of serosa-invasive gastric carcinoma patients who underwent surgery plus intraperitoneal hyperthermo-chemo-perfusion (IHCP). Gastric Cancer 2001 4 1 27 33 2-s2.0-0034931654 10.1007/s101200100013 (Pubitemid 32625932)
8. Yonemura Y., de Aretxabala X., Fujimura T., Fushida S., Katayama K., Bandou E., Sugiyama K., Kawamura T., Kinoshita K., Endou Y., Sasaki T., Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: final results of a randomized controlled study. Hepato-Gastroenterology 2001 48 42 1776 1782 2-s2.0-0035665643 (Pubitemid 34003526)
9. Yonemura Y., Endou Y., Shinbo M., Sasaki T., Hirano M., Mizumoto A., Matsuda T., Takao N., Ichinose M., Mizuno M., Miura M., Ikeda M., Ikeda S., Nakajima G., Yonemura J., Yuuba T., Masuda S., Kimura H., Matsuki N., Safety and efficacy of bidirectional chemotherapy for treatment of patients with peritoneal dissemination from gastric cancer: selection for cytoreductive surgery. Journal of Surgical Oncology 2009 100 4 311 316 2-s2.0-69749120079 10.1002/jso.21324
10. Glehen O., Gilly F. N., Arvieux C., Cotte E., Boutitie F., Mansvelt B., Bereder J. M., Lorimier G., Quenet F., Elias D., Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Annals of Surgical Oncology 2010 17 9 2370 2377 2-s2.0-77956341012 10.1245/s10434-010-1039-7
11. Yan T. D., Black D., Sugarbaker P. H., Zhu J., Yonemura Y., Petrou G., Morris D. L., A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer. Annals of Surgical Oncology 2007 14 10 2702 2713 2-s2.0-34648832063 10.1245/s10434-007-9487-4 (Pubitemid 47460649)
12. Jin-Yu H., Xu Y.-Y., Sun Z., Comparison different methods of intraoperative and intraperitoneal chemotherapy for patients with gastric cancer: a meta-analysis. Asian Pacific Journal of Cancer Prevention 2012 13 9 4379 4385
13. Sun J., Song Y., Wang Z., Benefit of hyperthermic intraperitoneal chemotherapy for patients with serosal invasion in gastric cancer: a meta-analysis of the randomized controlled trials. BMC Cancer 2012 12, article 526 10.1186/1471-2407-12-526
14. Yonemura Y., Elnemr A., Endou Y., Multidisciplinary therapy for treatment of patients with peritoneal carcinomatosis from gastric cancer. World Journal of Gastrointestinal Oncology 2010 2 2 85 97 10.4251/wjgo.v2.i2.85
15. Carboni F., di Giorgio A., di Lauro L., Criteri di appropriatezza clinica ed organizzativa nella diagnosi, terapia e follow-up delle carcinosi peritoneali. SICO, 2012, http://www.sicoonline.org/00-allegati-news/15- CarcinosiPeritoneali.pdf
16. Pyrhonen S., Kuitunen T., Nyandoto P., Kouri M., Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. British Journal of Cancer 1995 71 3 587 591 2-s2.0-0028959887
17. Hanazaki K., Mochizuki Y., Machida T., Yokoyama S., Sodeyama H., Sode Y., Wakabayashi M., Kawamura N., Miyazaki T., Post-operative chemotherapy in non-curative gastrectomy for advanced gastric cancer. Hepato-Gastroenterology 1999 46 26 1238 1243 2-s2.0-0032930512 (Pubitemid 29224825)
18. Kodera Y., Yamamura Y., Shimizu Y., Peritoneal washing cytology: prognostic value of positive findings in patients with gastric carcinoma undergoing a potentially curative resection. Journal of Surgical Oncology 1999 72 2 60 64
19. Roviello F., Caruso S., Marrelli D., Treatment of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: state of the art and future developments. Surgical Oncology 2011 20 1 e38 e54
20. Roviello F., Marrelli D., Neri A., Cerretani D., de Manzoni G., Pedrazzani C., Cioppa T., Nastri G., Giorgi G., Pinto E., Treatment of peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion (IHCP): postoperative outcome and risk factors for morbidity. World Journal of Surgery 2006 30 11 2033 2040 2-s2.0-33750492986 10.1007/s00268-006-0038-0 (Pubitemid 44655812)
21. Fujimoto S., Takahashi M., Mutou T., Successful intraperitoneal hyperthermic chemoperfusion for the prevention of post-operative peritoneal recurrence in patiens with advanced gastric carcinoma. Cancer 1999 85 3 529 534 (Pubitemid 29075274)
22. Sugarbaker P. H., Peritonectomy procedures. Annals of Surgery 1995 221 1 29 42 2-s2.0-0028797043
23. Sugarbaker P. H., Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis. Seminars in Surgical Oncology 1998 14 3 254 261 (Pubitemid 28146518)
24. Sugarbaker P. H., Observations concerning cancer spread within the peritoneal cavity and concepts supporting an ordered pathophysiology. Peritoneal Carcinomatosis: Principles and Management 1996 Boston, Mass, USA Kluwer Academic 79 100
25. Yonemura Y., Nojima N., Kawamura T., Mechanisms of formation of peritoneal dissemination. Peritoneal Dissemination: Molecular Mechanisms and the Latest Therapy 1998 Kanazawa, Japan Maeda Shoten 1 46
26. Stewart J. H. IV, Shen P., Edward A., Intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: current status and future directions. Annals of Surgical Oncology 2005 12 10 765 777 10.1245/ASO.2005.12. 001 (Pubitemid 41355928)
27. Gill R. S., Al-Adra D., Nagendran J., Tretement of gastric cancer with peritoneal carcinomatosis by cytoredctive surgery and HIPEC: a systematic review of survival, mortality, and morbidity. Journal of Surgical Oncology 2011 104 6 692 698 10.1002/jso.22017
28. Yang Q.-M., Kawamura T., Itoh H., Bando E., Nemoto M., Akamoto S., Furukawa H., Yonemura Y., Is PET-CT suitable for predicting lymph node status for gastric cancer? Hepato-Gastroenterology 2008 55 82-83 782 785 2-s2.0-44349103593 (Pubitemid 351741548)
29. Japanese Research Society for Gastric Cancer, The General Rules for Gastric Cancer Study 1995 1st Tokyo, Japan Kanahara Shuppan
30. Jacquet P., Sugarbaker P. H., Sugarbaker P. H., Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Peritoneal Carcinomatosis: Principles of Management 1996 Boston, Mass, USA Kluwer Academic 359 374
31. Ansaloni L., Lotti M., Campanati L., The prevention and treatement of peritoneal carcinomatosis from gastric cancer: a 2013 update. Journal of Cancer Research & Therapy 2013 1 1 54 59
32. Heiss M. M., Murawa P., Koralewski P., Kutarska E., Kolesnik O. O., Ivanchenko V. V., Dudnichenko A. S., Aleknaviciene B., Razbadauskas A., Gore M., Ganea-Motan E., Ciuleanu T., Wimberger P., Schmittel A., Schmalfeldt B., Burges A., Bokemeyer C., Lindhofer H., Lahr A., Parsons S. L., The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: results of a prospective randomized phase II/III trial. International Journal of Cancer 2010 127 9 2209 2221 2-s2.0-77954676136 10.1002/ijc.25423
33. Ströhlein M. A., Lordick F., Rüttinger D., Grützner K.-U., Schemanski O. C., Jäger M., Lindhofer H., Hennig M., Jauch K.-W., Peschel C., Heiss M. M., Immunotherapy of peritoneal carcinomatosis with the antibody catumaxomab in colon, gastric, or pancreatic cancer: an open-label, multicenter, phase I/II trial. Onkologie 2011 34 3 101 108 2-s2.0-79952257330 10.1159/000324667
34. Konstantinidis I. T., Young C., Tsikitis V. L., Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusione: the University of Arizona early experience. World Journal of Gastrointestinal Surgery 2012 4 6 135 140 10.4240/wjgs.v4.i6.135
35. Mizumoto A., Canabay E., Hiranoand M., Morbidity and mortality outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a single institution in Japan. Gastroenterology Research and Practice 2012 2012 5 836425 10.1155/2012/836425
36. Fujimoto S., Takahashi M., Mutou T., Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery. Cancer 1997 79 5 884 891 (Pubitemid 27089870)
37. Glehen O., Schreiber V., Cotte E., Sayag-Beaujard A. C., Osinsky D., Freyer G., François Y., Vignal J., Gilly F. N., Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer. Archives of Surgery 2004 139 1 20 26 2-s2.0-0347628945 10.1001/archsurg.139.1.20 (Pubitemid 38049613)
38. Allum W., Garofalo A., Degiuli M., Schuhmacher C., The first European union network of excellence for gastric cancer conference, Rome, Italy, April 2008. Gastric Cancer 2009 12 1 56 65 2-s2.0-65449124248 10.1007/s10120-009-0499- 6